Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
admission, alia, antagonist, arose, Aspire, CABTREOTM, cephalosporin, conclusion, constant, CRA, Curia, cycle, duty, East, EIFEL, embedded, eventual, fiduciary, flat, German, induction, inhibitor, IP, loyalty, Middle, MIEBO, noncompetitive, Papa, perfluorohexyloctane, prepaid, qui, realleging, representation, shown, Silbersher, SM, stockholder, tam, Tecnofarma, Thirteen, tort, warranty, waste, workforce
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view